Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 30, Issue 12, December 2005, Pages 1205-1304
 
MONOGRAPHS
 
  
 Dexelvucitabine.
Anti-HIV agent, Reverse transcriptase inhibitor.
McIntyre, J.A., Castaner, J.
Drugs Fut 2005, 30(12): 1205
Summary | Full Text: HTMLPDF 
 
  
  
 DP-VPA.
Antiepileptic drug.
Rosenberg, G., Friedman, J.E., Shapiro, I., Kozak, A.
Drugs Fut 2005, 30(12): 1212
Summary | Full Text: HTMLPDF 
 
  
  
 Indacaterol.
Asthma therapy, Treatment of COPD, β2-Adrenoceptor agonist.
Davies, S.L., Castaner, J.
Drugs Fut 2005, 30(12): 1219
Summary | Full Text: HTMLPDF 
 
  
  
 Lapatinib.
Oncolytic, Dual EGFR and erbB-2 inhibitor.
Boyd, B., Bozzo, J., Castaner, J., Bayes, M.
Drugs Fut 2005, 30(12): 1225
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 New oral iron-chelating drugs for the treatment of transfusional iron overload and other diseases.
Kotonghiorghes, G.J.
Drugs Fut 2005, 30(12): 1241
Summary | Full Text: HTMLPDF 
 
  
  
 Phytotherapies for diabetes.
Zareba, G., Serradell, N., Castaner, R., Davies, S.L., Prous, J., Mealy, N.
Drugs Fut 2005, 30(12): 1253
Summary | Full Text: HTMLPDF 
 
  
  
 Sitaxsentan: update on basic science studies and clinical trials supporting selective endothelin ETA receptor antagonism in the treatment of pulmonary arterial hypertension.
Davie, N.J., Coyne, T.C., Dixon, R.
Drugs Fut 2005, 30(12): 1283
Summary | Full Text: HTMLPDF 
 
  
  
 Pharmacostructural Index.
Drugs Fut 2005, 30(12): 1295
Full Text: PDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy